| (11) | Number of the document | 1367 |
| (21) | Number of the application | 95-0311 |
| (22) | Filing date of the application | 1993.11.12 |
| | Date of filing the request for examination | (de fond) 30.08.1995 |
| (71) | Name(s) of applicant(s), code of the country | IDEC PHARMACEUTICALS CORPORATION, US; |
| (72) | Name(s) of inventor(s), code of the country | ANDERSON, Darrell, R., US; RASTETTER, William, H., US; HANNA, Nabil, US; LEONARD, John, E., US; NEWMAN, Roland, A., US; REFF, Mitchell, E., US; |
| (73) | Name(s) of owner(s), code of the country | Biogen Idec Inc., US; |
| (54) | Title of the invention | Methods of B-cells lymphoma treatment, anti-CD20 antibodies, hybridoma |
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | A61K 38/00 (2006.01); A61K 47/48 (2006.01); C07K 16/28 (2006.01); |
| (19) | Country | US |
| (41) | Date of publication of the application | 1998.06.30 |
| (45) | Date of publication of patent granting decision: | 1999.12.31 |
| (47) | Date of issuance of patent | 2000.12.31 |
| (30) | Priority | 07/978,891, 1992.11.13, US; 08/149,099, 1993.11.03, US |
| (74) | Patent attorney | SKIDAN Natalia, Str. Andrei Doga 2/1, MD-2024, Chişinau, Republica Moldova |
| | Substantive examiner(s) | TIMONIN Alexandru |
| (85) | Date of introducing the national procedure | 1995.06.05 |
| (86) | International application | PCT/US1993/010953, 1993.11.12 |
| (87) | International publication | WO 1994/11026, 1994.05.26 |
| | Expired patents; Date of expiration | 2014.01.31 |
| | Payment for maintenance up to the date | 2013.11.12 |
| | Change of the owner | | Nr. şi data deciziei: | 8059, 2013.07.02 | | Datele iniţiale: | IDEC PHARMACEUTICALS CORPORATION, US | | Datele finale: | Biogen Idec Inc., US |
|